Pestle analysis on pharmaceutical industry
•Download as PPTX, PDF•
3 likes•4,797 views
The document discusses how various factors in the PESTEL analysis impact the pharmaceutical industry in India. It outlines how the political, economic, sociological, technological, ecological, and legal environments can positively or negatively influence the industry. A stable government, growing economy, educated society, advancing technology, balanced environment, and supportive laws create opportunities for pharmaceutical companies to develop and thrive.
Report
Share
Report
Share
Recommended
Pharmaceutical industry pestel analysis
The pharmaceutical industry in India is a rapidly growing sector that produces low-cost, high-quality drugs. It has a total market size of over $20 billion and has grown at around 12.5% annually over the past five years. Key players in the industry include Ranbaxy, Dr. Reddy's, Cipla, and Lupin. A PESTEL analysis identified political issues like price controls, social factors like an aging population and increased patient expectations, economic challenges from the global crisis, opportunities from new technologies, and an increasing focus on the environmental impact of the industry.
“SWOT ANALYSIS OF NEW PHARMACEUTICAL COMPANY”
Main Objective
To find the Strength, weakness, Opportunities and threat of the company and all new pharmaceutical companies.
To find out the perception and expectation of doctors and retailers towards the new pharmaceutical company.
Sub Objectives
To find out the big player of the market (Tough Competitor).
To find the way for new pharmaceutical company from tough competition.
To create strategy for company with the help of research detail.
To analyze Vadodara market for company.
To create good communication bridge between new company to doctors and retailers, that full feel all require expectation of both.
Glenmark analyst ppt
This presentation provides an overview of Glenmark Pharmaceuticals Limited (GPL), a specialty pharmaceutical company. GPL aims to emerge as a leading global integrated specialty company through proprietary research and development. The presentation outlines GPL's vision, therapeutic focus areas, research pipeline of 13 molecules including 8 new chemical entities and 5 biologics, and progress on key pipeline molecules like Oglemilast and GRC 6211. Financial details and global footprint of the overall Glenmark group are also included.
Pharma market
This presentation is brief introduction of Pharma Market and work pattern of MNCs (GSK is taken as example).This presentation was given by Faheem Siddiqui in Entrepreneur Conference at MBBS campus-Dadu of Sindh University on 09th October-13
Cipla final
Cipla is an India-based global pharmaceutical company whose goal is to ensure affordable medicine for all patients. It has a mission to be a leading healthcare provider using innovation and technology. Cipla has a competitive advantage of low-cost manufacturing through reverse engineering and a relative low-cost, high-skilled workforce in India. It is expanding globally through partnerships and acquisitions as patents expire on blockbuster drugs. Cipla is investing more in R&D and talent to develop new drugs and sustain its growth in international markets.
Dr. Reddy's Laboratories
Dr. Reddy's Laboratories is an Indian multinational pharmaceutical company. Case study presented me and my colleagues.
Mankind corporate presentation
This document provides an overview of the branded generics pharmaceutical market in India and the company Mankind Pharma. It summarizes Mankind's growth and success in the Indian market through organic expansion of its field force and market share, growing its portfolio of branded generic drugs, and expanding globally to over 12 countries. Key metrics shown include its rising domestic market share and rankings over time, high growth rates compared to industry averages, and leadership in key therapeutic segments like anti-diabetics and cardiac drugs.
Porter’S Five Force Model In Pharma Industries
This ppt describes well that how Porter's Five Force Model is used in Pharmaceutical Industris.......
Recommended
Pharmaceutical industry pestel analysis
The pharmaceutical industry in India is a rapidly growing sector that produces low-cost, high-quality drugs. It has a total market size of over $20 billion and has grown at around 12.5% annually over the past five years. Key players in the industry include Ranbaxy, Dr. Reddy's, Cipla, and Lupin. A PESTEL analysis identified political issues like price controls, social factors like an aging population and increased patient expectations, economic challenges from the global crisis, opportunities from new technologies, and an increasing focus on the environmental impact of the industry.
“SWOT ANALYSIS OF NEW PHARMACEUTICAL COMPANY”
Main Objective
To find the Strength, weakness, Opportunities and threat of the company and all new pharmaceutical companies.
To find out the perception and expectation of doctors and retailers towards the new pharmaceutical company.
Sub Objectives
To find out the big player of the market (Tough Competitor).
To find the way for new pharmaceutical company from tough competition.
To create strategy for company with the help of research detail.
To analyze Vadodara market for company.
To create good communication bridge between new company to doctors and retailers, that full feel all require expectation of both.
Glenmark analyst ppt
This presentation provides an overview of Glenmark Pharmaceuticals Limited (GPL), a specialty pharmaceutical company. GPL aims to emerge as a leading global integrated specialty company through proprietary research and development. The presentation outlines GPL's vision, therapeutic focus areas, research pipeline of 13 molecules including 8 new chemical entities and 5 biologics, and progress on key pipeline molecules like Oglemilast and GRC 6211. Financial details and global footprint of the overall Glenmark group are also included.
Pharma market
This presentation is brief introduction of Pharma Market and work pattern of MNCs (GSK is taken as example).This presentation was given by Faheem Siddiqui in Entrepreneur Conference at MBBS campus-Dadu of Sindh University on 09th October-13
Cipla final
Cipla is an India-based global pharmaceutical company whose goal is to ensure affordable medicine for all patients. It has a mission to be a leading healthcare provider using innovation and technology. Cipla has a competitive advantage of low-cost manufacturing through reverse engineering and a relative low-cost, high-skilled workforce in India. It is expanding globally through partnerships and acquisitions as patents expire on blockbuster drugs. Cipla is investing more in R&D and talent to develop new drugs and sustain its growth in international markets.
Dr. Reddy's Laboratories
Dr. Reddy's Laboratories is an Indian multinational pharmaceutical company. Case study presented me and my colleagues.
Mankind corporate presentation
This document provides an overview of the branded generics pharmaceutical market in India and the company Mankind Pharma. It summarizes Mankind's growth and success in the Indian market through organic expansion of its field force and market share, growing its portfolio of branded generic drugs, and expanding globally to over 12 countries. Key metrics shown include its rising domestic market share and rankings over time, high growth rates compared to industry averages, and leadership in key therapeutic segments like anti-diabetics and cardiac drugs.
Porter’S Five Force Model In Pharma Industries
This ppt describes well that how Porter's Five Force Model is used in Pharmaceutical Industris.......
Pakistan Pharmaceutical Market Overview (2015)
Pakistan has a growing pharmaceutical market valued at $2.6 billion in 2015. Systemic anti-infectives and alimentary tract and metabolism drugs make up nearly half of total market share. The top 20 pharmaceutical companies, including GlaxoSmithKline and Abbott Laboratories, account for over 50% of total market value. Major trading partners for pharmaceutical imports and exports include Afghanistan, Denmark, Switzerland, and Germany.
Cipla Presentation
This document provides an overview of Cipla Limited, an Indian pharmaceutical company. It discusses the company's history, vision, products, competitors, global presence, achievements, revenue breakdown, PESTLE analysis, Porter's five forces analysis, SWOT analysis, and key financial ratios. Cipla was founded in 1935 and is now a leading player in anti-infective and anti-asthmatic formulations. It has 44 manufacturing facilities in India and does business in over 170 countries worldwide.
Pharmaceutical industry India
The Indian pharmaceutical industry has grown significantly over the past few decades from a market dominated by foreign companies to becoming a major exporter and the 4th largest producer by volume globally. It meets 95% of domestic medical needs through companies manufacturing generic drugs and drug intermediates. The industry is projected to grow at 8% annually to $34 billion by 2012, higher than global growth, driven by factors like rising incomes, health awareness, and increasing treatment of medical conditions. The government provides various incentives and export promotion initiatives to support the industry's continued growth and ability to capture opportunities in outsourcing and the global market.
Indian Pharma Industry
The document discusses the Indian pharmaceutical industry. It provides an overview of major players, the Indian and global scenarios, future outlook, and areas for boosting competitiveness. The industry has grown significantly over time and India is now a top producer and exporter of generic drugs globally. The outlook remains positive with the market expected to reach $74 billion by 2020 and become one of the top ten markets worldwide. However, further investment in R&D and addressing regulatory issues can help strengthen the industry.
Sun pharma financial analysis 2008-2017
This is the financial analysis of sun pharmaceutical india ltd..financial analyis is use for check all the profits and loss during 10 years.pharmaceutical sector affects on a particular pharma company.chages in corporate governance and csr activity can affect more on this analysis.some of the major ratios can affect on shareholders,competitiors.share holders watch it and buy and sell sun pharma companies share.so comment below after watch this ppt.thank you.
Growth drivers in Indian Pharma Industry
Indian pharma industry growth is driven by Supply Side Drivers, demand-side drivers, and government policy support.
References:
https://www.ibef.org/industry/pharmaceutical-india.aspx
Product Mix of Novartis
The document provides an overview of Novartis including:
- Its mission is to discover, develop, and market innovative products to prevent and cure diseases while providing returns for shareholders.
- Key facts about its history, people, top brands, product mix, presence in different countries, and financial data including $56.6 billion in total sales in 2012.
- It invests heavily in R&D with locations around the world focusing on areas like rare/neglected diseases and responsible research practices.
Indian pharmaceutical industry
I have to try to share some knowledge about the Indian health care sector. I have put some data to get more and more knowledge which can easily understand.
Rural Marketing – Pharmaceuticals
The pharmaceutical market in rural India is growing rapidly due to increasing income and awareness of health issues. However, rural marketing faces several challenges including a dispersed population, lack of infrastructure and educated consumers. Elder Pharmaceuticals has launched a dedicated rural division called Elvista to target smaller towns and villages. Elvista aims to reach 1.5 million rural consumers by 2012 through dedicated sales staff and by promoting affordable medicines for common ailments. Novartis' Arogya Parivar initiative uses localized healthcare teams and adapted products to improve access to treatment in rural communities across several states. Leading companies are conducting health camps and partnering with local organizations to promote awareness and education programs tailored for rural needs.
Effect of macro economic factors on Pharmaceutical Industry
The document discusses the impact of various macroeconomic factors on the pharmaceutical industry. It states that an increase in GDP leads to higher incomes and spending on healthcare, boosting the industry. However, lower GDP reduces funds for healthcare infrastructure. Government initiatives like healthcare programs and pharmaceutical parks aim to increase healthcare access and industry investments. Trade wars and foreign investments also impact drug exports, imports of ingredients, and industry earnings. Overall, macroeconomic, regulatory, and policy changes can significantly influence the pharmaceutical sector.
Pharmaceutical Supply Chain
This document summarizes a study on supply chain practices in the pharmaceutical industry. It finds that the pharmaceutical supply chain is very fragmented, complex, and global. It operates in a competitive environment while also needing to ensure high regulations for patient safety. An effective supply chain can reduce costs and increase efficiency. However, it also faces risks like counterfeiting and needs strong risk management practices. The document outlines Pfizer's successful risk management efforts and FoxMeyer Drug Company's risk management failure which led to bankruptcy. Overall, the pharmaceutical supply chain is highly complex and regulated, with high costs of success or failure.
Comprehensive Analysis on: Business Strategy of Square Pharmaceuticals Limited
Square Pharmaceuticals Limited is the largest pharmaceutical company in Bangladesh, holding a 19.18% market share as of 2013. It has a diverse product portfolio and focuses on both cost leadership and differentiation strategies for different product categories. The company emphasizes quality, ethics, and social responsibility. It aims to improve people's health while generating wealth for shareholders. Square faces competition from large MNCs but also has opportunities in exports, research collaborations, and an increasing domestic market. Maintaining quality, investing in innovation, and navigating regulations will be key to sustaining its leading position in the industry.
Dr reddy's
Dr. Reddy's Laboratories is an Indian pharmaceutical company founded in 1984 and headquartered in Hyderabad, India. It produces active pharmaceutical ingredients, finished dosages, and biologics. Dr. Reddy's controls its entire supply chain to offer high quality, affordable medicines while maintaining quality at every stage. It has 20,000 employees worldwide and facilities in India, the US, UK, and Mexico. Dr. Reddy's goals include becoming a global, integrated mid-sized pharmaceutical company through diversifying into generics and specialty medicines across emerging markets.
Case Study Analysis on GlaxoSmithkline
Case study completed for the module : Understanding Strategic Management
University of Bradford .
Hp case study
Hewlett Packard Corporation was founded in 1939 by Bill Hewlett and Dave Packard in a garage in Palo Alto, California. HP produces personal computing devices, enterprise servers, storage devices, and printers and imaging products. The document analyzes HP's strategy using various frameworks including SWOT analysis, BCG matrix, IE matrix, and QSPM to recommend the strategic option of horizontal integration for HP to pursue based on its strengths in a rapidly growing market.
SWOT Analysis of Sunpharma
Sun Pharmaceuticals is an Indian pharmaceutical company with strong global presence. It has strengths in its expanding emerging markets business, successful acquisition of Ranbaxy, ANDA approvals, and brand presence in India. Opportunities exist in oncology drugs, expanding retail offerings, outsourcing manufacturing, and leveraging Ranbaxy's OTC drugs. However, it faces weaknesses like underperforming subsidiaries, regulatory issues, and pricing controls. Threats include growing generic competition, currency fluctuations, drug pricing policies, and potential financial crunch from acquisitions.
Sun pharma
Sun Pharmaceutical Industries was founded in 1983 in Kolkata, India by Dilip Shanghvi. It has since grown to become one of the largest pharmaceutical companies in India through strategic acquisitions and a focus on generic drugs. Some key milestones include acquiring Caraco Pharmaceutical Labs in 1997, acquiring a plant in Ohio in 2005, and merging with Ranbaxy Laboratories in 2014. Sun Pharma has a presence across multiple therapeutic areas and geographic regions. It has a market share of 3.2% in India and follows strict regulatory guidelines. With the aging global population and rising incomes, Sun Pharma is well positioned for continued growth in the coming years through synergies from acquisitions and expanding in emerging markets
Sun pharma- A complete company review, analysis of crisis and realistic recom...
Sun pharma has been the most talked about Indian pharma company for being in the news several times for its unresolved issues with the US FDA regarding the Halol and Mohali plant.
This presentation has analysed the situation and it suggests various solutions for the same.
indian Pharmaceutical industry export import overview
Pharmaceutical Industry-EXPORT IMPORT INDIA
The pharmaceutical industry develops, produces, and markets drugs or pharmaceuticals licensed for use as medications. Pharmaceutical companies are allowed to deal in generic and/or brand medications and medical devices
Pharmaceutical Industry: The Challenges and the Opportunities
Gino Martini, EIPG President
Presentation at Symposium at the Faculdade de Farmácia, Universidade de Lisboa, Lisbon 2012.
India's leading pharmaceutical company 2021
Insights Success’ latest issue, India's Leading Pharmaceutical Company - 2021, in order to highlight one of the renowned companies – ‘Century Pharmaceuticals Limited,’ that is changing the face of the pharmaceutical industry.
How Can Pharma Sales Leaders Create A Winning Sales Organisation?
Inside this Issue
1. Interview with Salil Kallianpur – with Anup Soans, Editor – MedicinMan
“There is much work to be done and a unified pharma industry can prove to be a valuable ally to the government.”
2. Patient-centricity: How Pharma Can Move from Intention to Action by Hanno Wolfram
Patient-centricity begins with moving from talking about the patient to talking to the patient
3. The Corporate Halo Effect by Vivek Hattangadi
How a great corporate brand elevates a company’s products in the minds of doctors and patients
4. For a Positive Attitude, Clean Your Mind’s Windows by Asheesh Kumar Patel
A bad attitude is a learned behavior and can be unlearned when we discover it’s source
5. The Three Transformations for Leadership by Srinivasan Athmanathan
Three key professional traits that every successful leader must possess
6. Book Review: Feather in a C.A.P. by Kamalesh Subramanian
A corporate saga with valuable lessons for professionals of all backgrounds
More Related Content
What's hot
Pakistan Pharmaceutical Market Overview (2015)
Pakistan has a growing pharmaceutical market valued at $2.6 billion in 2015. Systemic anti-infectives and alimentary tract and metabolism drugs make up nearly half of total market share. The top 20 pharmaceutical companies, including GlaxoSmithKline and Abbott Laboratories, account for over 50% of total market value. Major trading partners for pharmaceutical imports and exports include Afghanistan, Denmark, Switzerland, and Germany.
Cipla Presentation
This document provides an overview of Cipla Limited, an Indian pharmaceutical company. It discusses the company's history, vision, products, competitors, global presence, achievements, revenue breakdown, PESTLE analysis, Porter's five forces analysis, SWOT analysis, and key financial ratios. Cipla was founded in 1935 and is now a leading player in anti-infective and anti-asthmatic formulations. It has 44 manufacturing facilities in India and does business in over 170 countries worldwide.
Pharmaceutical industry India
The Indian pharmaceutical industry has grown significantly over the past few decades from a market dominated by foreign companies to becoming a major exporter and the 4th largest producer by volume globally. It meets 95% of domestic medical needs through companies manufacturing generic drugs and drug intermediates. The industry is projected to grow at 8% annually to $34 billion by 2012, higher than global growth, driven by factors like rising incomes, health awareness, and increasing treatment of medical conditions. The government provides various incentives and export promotion initiatives to support the industry's continued growth and ability to capture opportunities in outsourcing and the global market.
Indian Pharma Industry
The document discusses the Indian pharmaceutical industry. It provides an overview of major players, the Indian and global scenarios, future outlook, and areas for boosting competitiveness. The industry has grown significantly over time and India is now a top producer and exporter of generic drugs globally. The outlook remains positive with the market expected to reach $74 billion by 2020 and become one of the top ten markets worldwide. However, further investment in R&D and addressing regulatory issues can help strengthen the industry.
Sun pharma financial analysis 2008-2017
This is the financial analysis of sun pharmaceutical india ltd..financial analyis is use for check all the profits and loss during 10 years.pharmaceutical sector affects on a particular pharma company.chages in corporate governance and csr activity can affect more on this analysis.some of the major ratios can affect on shareholders,competitiors.share holders watch it and buy and sell sun pharma companies share.so comment below after watch this ppt.thank you.
Growth drivers in Indian Pharma Industry
Indian pharma industry growth is driven by Supply Side Drivers, demand-side drivers, and government policy support.
References:
https://www.ibef.org/industry/pharmaceutical-india.aspx
Product Mix of Novartis
The document provides an overview of Novartis including:
- Its mission is to discover, develop, and market innovative products to prevent and cure diseases while providing returns for shareholders.
- Key facts about its history, people, top brands, product mix, presence in different countries, and financial data including $56.6 billion in total sales in 2012.
- It invests heavily in R&D with locations around the world focusing on areas like rare/neglected diseases and responsible research practices.
Indian pharmaceutical industry
I have to try to share some knowledge about the Indian health care sector. I have put some data to get more and more knowledge which can easily understand.
Rural Marketing – Pharmaceuticals
The pharmaceutical market in rural India is growing rapidly due to increasing income and awareness of health issues. However, rural marketing faces several challenges including a dispersed population, lack of infrastructure and educated consumers. Elder Pharmaceuticals has launched a dedicated rural division called Elvista to target smaller towns and villages. Elvista aims to reach 1.5 million rural consumers by 2012 through dedicated sales staff and by promoting affordable medicines for common ailments. Novartis' Arogya Parivar initiative uses localized healthcare teams and adapted products to improve access to treatment in rural communities across several states. Leading companies are conducting health camps and partnering with local organizations to promote awareness and education programs tailored for rural needs.
Effect of macro economic factors on Pharmaceutical Industry
The document discusses the impact of various macroeconomic factors on the pharmaceutical industry. It states that an increase in GDP leads to higher incomes and spending on healthcare, boosting the industry. However, lower GDP reduces funds for healthcare infrastructure. Government initiatives like healthcare programs and pharmaceutical parks aim to increase healthcare access and industry investments. Trade wars and foreign investments also impact drug exports, imports of ingredients, and industry earnings. Overall, macroeconomic, regulatory, and policy changes can significantly influence the pharmaceutical sector.
Pharmaceutical Supply Chain
This document summarizes a study on supply chain practices in the pharmaceutical industry. It finds that the pharmaceutical supply chain is very fragmented, complex, and global. It operates in a competitive environment while also needing to ensure high regulations for patient safety. An effective supply chain can reduce costs and increase efficiency. However, it also faces risks like counterfeiting and needs strong risk management practices. The document outlines Pfizer's successful risk management efforts and FoxMeyer Drug Company's risk management failure which led to bankruptcy. Overall, the pharmaceutical supply chain is highly complex and regulated, with high costs of success or failure.
Comprehensive Analysis on: Business Strategy of Square Pharmaceuticals Limited
Square Pharmaceuticals Limited is the largest pharmaceutical company in Bangladesh, holding a 19.18% market share as of 2013. It has a diverse product portfolio and focuses on both cost leadership and differentiation strategies for different product categories. The company emphasizes quality, ethics, and social responsibility. It aims to improve people's health while generating wealth for shareholders. Square faces competition from large MNCs but also has opportunities in exports, research collaborations, and an increasing domestic market. Maintaining quality, investing in innovation, and navigating regulations will be key to sustaining its leading position in the industry.
Dr reddy's
Dr. Reddy's Laboratories is an Indian pharmaceutical company founded in 1984 and headquartered in Hyderabad, India. It produces active pharmaceutical ingredients, finished dosages, and biologics. Dr. Reddy's controls its entire supply chain to offer high quality, affordable medicines while maintaining quality at every stage. It has 20,000 employees worldwide and facilities in India, the US, UK, and Mexico. Dr. Reddy's goals include becoming a global, integrated mid-sized pharmaceutical company through diversifying into generics and specialty medicines across emerging markets.
Case Study Analysis on GlaxoSmithkline
Case study completed for the module : Understanding Strategic Management
University of Bradford .
Hp case study
Hewlett Packard Corporation was founded in 1939 by Bill Hewlett and Dave Packard in a garage in Palo Alto, California. HP produces personal computing devices, enterprise servers, storage devices, and printers and imaging products. The document analyzes HP's strategy using various frameworks including SWOT analysis, BCG matrix, IE matrix, and QSPM to recommend the strategic option of horizontal integration for HP to pursue based on its strengths in a rapidly growing market.
SWOT Analysis of Sunpharma
Sun Pharmaceuticals is an Indian pharmaceutical company with strong global presence. It has strengths in its expanding emerging markets business, successful acquisition of Ranbaxy, ANDA approvals, and brand presence in India. Opportunities exist in oncology drugs, expanding retail offerings, outsourcing manufacturing, and leveraging Ranbaxy's OTC drugs. However, it faces weaknesses like underperforming subsidiaries, regulatory issues, and pricing controls. Threats include growing generic competition, currency fluctuations, drug pricing policies, and potential financial crunch from acquisitions.
Sun pharma
Sun Pharmaceutical Industries was founded in 1983 in Kolkata, India by Dilip Shanghvi. It has since grown to become one of the largest pharmaceutical companies in India through strategic acquisitions and a focus on generic drugs. Some key milestones include acquiring Caraco Pharmaceutical Labs in 1997, acquiring a plant in Ohio in 2005, and merging with Ranbaxy Laboratories in 2014. Sun Pharma has a presence across multiple therapeutic areas and geographic regions. It has a market share of 3.2% in India and follows strict regulatory guidelines. With the aging global population and rising incomes, Sun Pharma is well positioned for continued growth in the coming years through synergies from acquisitions and expanding in emerging markets
Sun pharma- A complete company review, analysis of crisis and realistic recom...
Sun pharma has been the most talked about Indian pharma company for being in the news several times for its unresolved issues with the US FDA regarding the Halol and Mohali plant.
This presentation has analysed the situation and it suggests various solutions for the same.
indian Pharmaceutical industry export import overview
Pharmaceutical Industry-EXPORT IMPORT INDIA
The pharmaceutical industry develops, produces, and markets drugs or pharmaceuticals licensed for use as medications. Pharmaceutical companies are allowed to deal in generic and/or brand medications and medical devices
Pharmaceutical Industry: The Challenges and the Opportunities
Gino Martini, EIPG President
Presentation at Symposium at the Faculdade de Farmácia, Universidade de Lisboa, Lisbon 2012.
What's hot (20)
Effect of macro economic factors on Pharmaceutical Industry
Effect of macro economic factors on Pharmaceutical Industry
Comprehensive Analysis on: Business Strategy of Square Pharmaceuticals Limited
Comprehensive Analysis on: Business Strategy of Square Pharmaceuticals Limited
Sun pharma- A complete company review, analysis of crisis and realistic recom...
Sun pharma- A complete company review, analysis of crisis and realistic recom...
indian Pharmaceutical industry export import overview
indian Pharmaceutical industry export import overview
Pharmaceutical Industry: The Challenges and the Opportunities
Pharmaceutical Industry: The Challenges and the Opportunities
Similar to Pestle analysis on pharmaceutical industry
India's leading pharmaceutical company 2021
Insights Success’ latest issue, India's Leading Pharmaceutical Company - 2021, in order to highlight one of the renowned companies – ‘Century Pharmaceuticals Limited,’ that is changing the face of the pharmaceutical industry.
How Can Pharma Sales Leaders Create A Winning Sales Organisation?
Inside this Issue
1. Interview with Salil Kallianpur – with Anup Soans, Editor – MedicinMan
“There is much work to be done and a unified pharma industry can prove to be a valuable ally to the government.”
2. Patient-centricity: How Pharma Can Move from Intention to Action by Hanno Wolfram
Patient-centricity begins with moving from talking about the patient to talking to the patient
3. The Corporate Halo Effect by Vivek Hattangadi
How a great corporate brand elevates a company’s products in the minds of doctors and patients
4. For a Positive Attitude, Clean Your Mind’s Windows by Asheesh Kumar Patel
A bad attitude is a learned behavior and can be unlearned when we discover it’s source
5. The Three Transformations for Leadership by Srinivasan Athmanathan
Three key professional traits that every successful leader must possess
6. Book Review: Feather in a C.A.P. by Kamalesh Subramanian
A corporate saga with valuable lessons for professionals of all backgrounds
Mipm report team 3
The document provides an overview of the pharmaceutical industry in India and analyzes two pharmaceutical companies - Eris Lifesciences and Granules. It discusses that the Indian pharmaceutical industry has low production costs and supplies over 50% of global generic drug demand. A SWOT analysis identifies strengths like low costs and chemistry skills, and weaknesses like price regulation. Eris Lifesciences and Granules were selected for analysis as they focus on producing drugs domestically rather than importing raw materials. Eris Lifesciences in particular has leading market shares, high margins, and growing profits.
Mipm report team 3
The document provides an overview of the pharmaceutical industry in India and analyzes two pharmaceutical companies - Eris Lifesciences and Granules. It discusses that the Indian pharmaceutical industry has low production costs and supplies over 50% of global generic drug demand. A SWOT analysis identifies strengths like low costs and chemistry skills, and weaknesses like price regulation. Eris Lifesciences and Granules were selected for analysis as they focus on producing drugs domestically rather than importing raw materials. Eris Lifesciences in particular has leading market shares, high margins, and growing profits.
PowerPoint Presentation
I have completed a internship in Brand Awareness and sale in company 1MG and also financial analysis of two Business of the Pharmaceutical industry.
Pharma Policy 2017 - Read it in MedicinMan September 2017 Issue
1. Draft Pharma Policy: The Good, The Bad and The Ugly...............................................1
Interview with Sunil Attavar
2. Career Brand Plan: A Career Stepping
Stone..........................................................9
Soham Wagh
3. Succeeding as Country GM at GSK: A Whitepaper..............................................12
Sundar Ramachandran
4. Role of Digital in the Customer Journey ....................................................................21
Salil Kallianpur
5. Executive Function Disorder .................24
Vivek Hattangadi
Nikroxx file pdf
This document is a dissertation report submitted by Nikhil Jhamb to Kurukshetra University in partial fulfillment of an MBA degree. The report analyzes the management information system reports of 10 pharmaceutical companies in Paonta Sahib, India. It includes an introduction on the pharmaceutical industry in India, profiles of the 10 companies studied, a chapter on management information systems, the research methodology used, an analysis and interpretation of data from the companies' MIS reports, findings from the study, and recommendations and conclusions. The key points provided on the pharmaceutical industry in India note that supply is higher for traditional therapeutic segments typical of a developing market, while demand is very high for certain therapeutic segments and will change as life expectancy and literacy
Nikroxx file pdf
This document is a dissertation report submitted by Nikhil Jhamb to Kurukshetra University in partial fulfillment of an MBA degree. The report analyzes the management information system reports of 10 pharmaceutical companies in Paonta Sahib, India. It includes an introduction to the Indian pharmaceutical industry, profiles of the 10 companies studied, a description of the research methodology used, an analysis and interpretation of data from the companies' MIS reports, findings from the study, and recommendations and conclusions. The Indian pharmaceutical industry is a $4.5 billion industry that is highly fragmented across more than 20,000 registered units and is an important industry in India.
Counterfeit Drugs Presentation.pptx
1) Pakistan has a significant problem with counterfeit drugs, with estimates that 15% of medicines worldwide and 36% of anti-malarial drugs in Southeast Asia are counterfeit.
2) The pharmaceutical industry in Pakistan is dominated by local firms and the top 10 firms control 46% of the market. The industry has been growing at 15% annually.
3) In response to the counterfeit drug crisis in 2011, the Drug Regulatory Authority of Pakistan (DRAP) was established to regulate the industry and implement policies around pricing, imports/exports, and quality control.
Sector Analysis - Health Care
The document provides an analysis of the healthcare sector. It discusses the industries that make up the sector, including pharmaceuticals, biotechnology, medical devices, health insurers, hospitals, and more. It analyzes the sector's performance, valuation metrics, macroeconomic factors like government spending and regulation, and demographic trends. Several investment firms are cited that believe the sector will continue growing due to an aging population but also face volatility due to the election and drug pricing debates. Biotech companies are seen as particularly promising for outperformance.
BSA_April_2016
This document provides information on an Inductively Coupled Plasma Mass Spectrometer (ICPMS-2030) product. The key points are:
1. The ICPMS-2030 has new features including first method development and diagnostic assistant functions for innovation, and a newly developed collision cell that achieves high sensitivity with low interference for accuracy.
2. It utilizes proprietary technology that realizes low running costs, among the industry’s best for economic benefits.
3. In summary, the ICPMS-2030 product provides innovative assistant functions, high accuracy through a new collision cell, and low running costs through proprietary technology.
A Study of generic drugs
This document is a project report submitted by Mr. Santosh Panchakshari Salgare to the Department of Management Sciences at Savitribai Phule Pune University. The project involved conducting a study to understand the prescription pattern of generic drugs at Hindustan Antibiotics Limited in Pimpri, Pune. The report includes an introduction to the pharmaceutical industry, company profile of Hindustan Antibiotics Limited, objectives, methodology, findings and analysis of the study, and conclusions and recommendations.
Indian Pharma - An Overview by IDMA Secretary General Daara B Patel
This document discusses the Indian pharmaceutical industry and its growth opportunities. It notes that India is a major global supplier of affordable, high-quality medicines and has significant manufacturing capabilities and regulatory approvals. The Indian drug market is large and growing, fueled by increasing access, acceptance, and affordability of medicines in India. Indian companies are also major exporters and are collaborating with international partners. R&D investment is growing to develop new products and capture patent expiration opportunities.
Biocon's Eureka Moment - Mint Asia
1) Alzumab, an antibody developed by Biocon Ltd to treat psoriasis, showed promising results in clinical trials, effectively treating a patient's psoriasis within 8 weeks.
2) Alzumab works through the Th17 immune pathway and has the potential to treat over 100 autoimmune diseases. It was launched in India to treat psoriasis in August 2013.
3) Biocon's development of Alzumab was a breakthrough for the company and Indian innovation, as it was developed through a decade-long process and may establish credibility for Indian clinical research.
Market Structure and Factors influencing demand and supply of Cipla Ltd.
Cipla is an Indian pharmaceutical company and one of the leading players globally. It was founded in 1935 and has since expanded worldwide. The Indian pharmaceutical industry is large, valued at $41 billion, and supplies 20% of global medicines by volume. The industry has an oligopolistic market structure dominated by a few major players like Cipla, Sun Pharma, and Lupin. Demand for pharmaceuticals is driven by increased health awareness, insurance, government schemes, and rising incomes. Supply is affected by regulations, R&D capabilities, and access to new technologies. Cipla faces challenges from price controls, supply chain issues, and pandemic-related demand fluctuations.
Most Leading Generic Pharma Companies to Watch in 2022.pdf
Insights care latest edition, "10 Most Leading Generic Pharma Companies to Watch in 2022" will be signifying the shift in the industry's operations to reach where the customer headed.
Porter’S Forces In Pharmaceutical ind
The Indian pharmaceutical industry faces competitive forces including the threat of new entrants, bargaining power of customers and suppliers, and competitive rivalry among existing firms. The document discusses Porter's five forces framework and outlines strategies for Indian pharmaceutical companies to boost competitiveness such as increasing R&D expenditures, rationalizing drug price controls, improving industry-academic relationships, and exploiting opportunities in generic drugs and traditional medicines. It also analyzes strengths, weaknesses, opportunities and threats for the industry.
Indian pharmaceutical indutry 2015
Introduction Indian Pharmaceutical market, SWOT analysis, PEST Analysis, Timeline analysis of Sun Pharma, Glaxo Smith Kline, Mankind, CIPLA and Zydus Cadila.
Global industrial hemp market
By Product Type (Seeds, Fiber, Shivs, and Stalks), By Source (Natural and Organic), By Applications (Animal Care, Textiles, Automotive, Furniture, Food & Beverages, Paper, Construction Materials, and Personal Care), and By Region (North America, Europe, Asia Pacific, Latin America and Middle East & Africa)
https://www.prophecymarketinsights.com/market_insight/Global-Industrial-Hemp-Market-By-1070
Medical Instrument and Supply Manufacturing Industry Report
The document provides an overview of the medical instrument and supply manufacturing industry. It discusses key factors such as an aging population driving increased demand, regulations from the FDA and PPACA, and consolidation in the industry with larger companies acquiring smaller innovative ones. While the industry faces pressures from regulations and increasing wages, overall growth is expected to continue due to demographic trends and the need for ongoing innovation in medical technology. The industry provides opportunities for Oregon companies if they maintain innovation and low costs.
Similar to Pestle analysis on pharmaceutical industry (20)
How Can Pharma Sales Leaders Create A Winning Sales Organisation?
How Can Pharma Sales Leaders Create A Winning Sales Organisation?
Pharma Policy 2017 - Read it in MedicinMan September 2017 Issue
Pharma Policy 2017 - Read it in MedicinMan September 2017 Issue
Indian Pharma - An Overview by IDMA Secretary General Daara B Patel
Indian Pharma - An Overview by IDMA Secretary General Daara B Patel
Market Structure and Factors influencing demand and supply of Cipla Ltd.
Market Structure and Factors influencing demand and supply of Cipla Ltd.
Most Leading Generic Pharma Companies to Watch in 2022.pdf
Most Leading Generic Pharma Companies to Watch in 2022.pdf
Medical Instrument and Supply Manufacturing Industry Report
Medical Instrument and Supply Manufacturing Industry Report
More from Arihant Zunjarvad
NRI Investment Guidelines..
An NRI is defined as an Indian citizen who resides outside India for at least 182 days in a financial year according to the Indian Income Tax Act of 1961. To qualify as an NRI, an individual must reside outside India for over 182 days per year and either hold Indian citizenship or be a person of Indian origin. NRIs can invest in the Indian stock market under the Portfolio Investment Scheme for NRIs established by the Reserve Bank of India. Key steps for NRI investments include obtaining a PAN card, opening an NRE/NRO bank account, and opening a demat/trading account. NRIs have certain limits on the amount they can invest in individual companies.
Nse products
Its all about NSE and It's product offerings as well as the role of Forward Market Commission. Thank You. #Aj
Investment Pattern on the basis of investors risk profile
It is an internship project done by me in order to know the risk profile of investors and how investors respond with respect to the risk.
I found it really a great experience in my MBA graduation.
Thank you.
Ethics in Service marketing,,!!
This document discusses service marketing ethics, which establishes standards for determining right and wrong actions in service marketing. It examines the moral principles behind operating and regulating service marketing in areas like products, pricing, distribution, promotion, and advertising. Following ethical practices in service marketing can help develop positive attitudes, trust with stakeholders, a good image, and long-term business success.
Self introduction by aj
Arihant K Zunjarvad is introducing himself. According to Jain mythology, an Arihant is someone who destroys all karmas. Arihant also means to destroy enemies. Arihant completed his primary education in Ainapur and secondary education in Kothali Kuppanwadi. He obtained his B.Com degree from TUSWET’s Arts and Commerce College with 85% marks. He is currently pursuing his MBA from Rani Channamma University with grades of 71.42% and 75.60% in the first and second semesters respectively. Some of his achievements include winning prizes for drama competitions in school and ranking third in his B.Com college
Presentation on managementetiquettes
This presentation discusses managerial etiquettes. It begins by defining etiquette as good behavior that distinguishes humans from animals and as using common sense. It then lists different types of etiquettes, including social, wedding, meeting, telephone, eating, business, interview, and managerial etiquettes. For managerial etiquette specifically, it says this involves behaving appropriately at work to make a good impression. The presentation then provides examples of managerial etiquettes from A to Z, such as respecting others, following rules, not disturbing others, being friendly, being honest, recognizing good work, saying please and thank you, understanding others, and not being vague or weak-minded.
Presentation on Patanjali Ltd.
This document provides an overview of Patanjali Ayurveda Ltd., an Indian consumer goods company. It discusses the company's vision to become a leading ayurvedic company globally and reintroduce Indian ayurveda. The document outlines Patanjali's products, partnerships, achievements in becoming a giant FMCG company within 5 years, and future goals such as achieving 10,000 crore in business and expanding globally within the next 5 years.
Presentation on Marketing : Pricing strategies
This document discusses new product pricing strategies. It defines a new product and pricing strategy. There are two main methods for pricing new products: market skimming and penetration pricing. Market skimming involves setting a high initial price to recoup costs and attract attention, while penetration pricing uses lower prices to target a wider customer base and increase sales. Both methods have advantages like revenue generation and brand awareness, as well as disadvantages like lower customer reach. The document provides examples and outlines the characteristics of each pricing approach.
Presentation on Managerial Etiquettes
This presentation discusses managerial etiquettes. It begins by defining etiquette as good behavior that distinguishes humans from animals and as using common sense. It then lists different types of etiquettes, including social, wedding, meeting, telephone, eating, business, interview, and managerial etiquettes. For managerial etiquette specifically, it says this involves behaving appropriately at work to make a good impression. The presentation then provides examples of managerial etiquettes from A to Z, such as respecting others, following rules, not disturbing others, being honest, recognizing good work, saying please and thank you, understanding others, and not being vague or weak-minded.
Presentation on Patanjali Ltd.
Efforts tells where u have to be,
So do efforts and reach higher levels,
Rani Channamma University..
More from Arihant Zunjarvad (10)
Investment Pattern on the basis of investors risk profile
Investment Pattern on the basis of investors risk profile
Recently uploaded
高仿英国伦敦艺术大学毕业证（ual毕业证书）文凭证书原版一模一样
原版一模一样【微信：741003700 】【英国伦敦艺术大学毕业证（ual毕业证书）文凭证书】【微信：741003700 】学位证，留信认证（真实可查，永久存档）offer、雅思、外壳等材料/诚信可靠,可直接看成品样本，帮您解决无法毕业带来的各种难题！外壳，原版制作，诚信可靠，可直接看成品样本。行业标杆！精益求精，诚心合作，真诚制作！多年品质 ,按需精细制作，24小时接单,全套进口原装设备。十五年致力于帮助留学生解决难题，包您满意。
本公司拥有海外各大学样板无数，能完美还原海外各大学 Bachelor Diploma degree, Master Degree Diploma
1:1完美还原海外各大学毕业材料上的工艺：水印，阴影底纹，钢印LOGO烫金烫银，LOGO烫金烫银复合重叠。文字图案浮雕、激光镭射、紫外荧光、温感、复印防伪等防伪工艺。材料咨询办理、认证咨询办理请加学历顾问Q/微741003700
留信网认证的作用:
1:该专业认证可证明留学生真实身份
2:同时对留学生所学专业登记给予评定
3:国家专业人才认证中心颁发入库证书
4:这个认证书并且可以归档倒地方
5:凡事获得留信网入网的信息将会逐步更新到个人身份内，将在公安局网内查询个人身份证信息后，同步读取人才网入库信息
6:个人职称评审加20分
7:个人信誉贷款加10分
8:在国家人才网主办的国家网络招聘大会中纳入资料，供国家高端企业选择人才
Tiểu luận: PURPOSE OF BUDGETING IN SME.docx
Luận Văn Group hỗ trợ viết luận văn thạc sĩ,chuyên đề,khóa luận tốt nghiệp, báo cáo thực tập, Assignment, Essay
Zalo/Sdt 0967 538 624/ 0886 091 915 Website:lamluanvan.net
Tham gia nhóm hỗ trợ viết bài fb: https://www.facebook.com/groups/285625754522599?locale=vi_VN
China's Investment Leader - Dr. Alyce SU
In World Expo 2010 Shanghai – the most visited Expo in the World History
https://www.britannica.com/event/Expo-Shanghai-2010
China’s official organizer of the Expo, CCPIT (China Council for the Promotion of International Trade https://en.ccpit.org/) has chosen Dr. Alyce Su as the Cover Person with Cover Story, in the Expo’s official magazine distributed throughout the Expo, showcasing China’s New Generation of Leaders to the World.
1比1复刻(ksu毕业证书)美国堪萨斯州立大学毕业证本科文凭证书原版一模一样
原版定制【微信:bwp0011】《(ksu毕业证书)美国堪萨斯州立大学毕业证本科文凭证书》【微信:bwp0011】成绩单 、雅思、外壳、留信学历认证永久存档查询，采用学校原版纸张、特殊工艺完全按照原版一比一制作（包括：隐形水印，阴影底纹，钢印LOGO烫金烫银，LOGO烫金烫银复合重叠，文字图案浮雕，激光镭射，紫外荧光，温感，复印防伪）行业标杆！精益求精，诚心合作，真诚制作！多年品质 ,按需精细制作，24小时接单,全套进口原装设备，十五年致力于帮助留学生解决难题，业务范围有加拿大、英国、澳洲、韩国、美国、新加坡，新西兰等学历材料，包您满意。
【业务选择办理准则】
一、工作未确定，回国需先给父母、亲戚朋友看下文凭的情况，办理一份就读学校的毕业证【微信bwp0011】文凭即可
二、回国进私企、外企、自己做生意的情况，这些单位是不查询毕业证真伪的，而且国内没有渠道去查询国外文凭的真假，也不需要提供真实教育部认证。鉴于此，办理一份毕业证【微信bwp0011】即可
三、进国企，银行，事业单位，考公务员等等，这些单位是必需要提供真实教育部认证的，办理教育部认证所需资料众多且烦琐，所有材料您都必须提供原件，我们凭借丰富的经验，快捷的绿色通道帮您快速整合材料，让您少走弯路。
留信网认证的作用:
1:该专业认证可证明留学生真实身份
2:同时对留学生所学专业登记给予评定
3:国家专业人才认证中心颁发入库证书
4:这个认证书并且可以归档倒地方
5:凡事获得留信网入网的信息将会逐步更新到个人身份内，将在公安局网内查询个人身份证信息后，同步读取人才网入库信息
6:个人职称评审加20分
7:个人信誉贷款加10分
8:在国家人才网主办的国家网络招聘大会中纳入资料，供国家高端企业选择人才
【关于价格问题（保证一手价格）】
我们所定的价格是非常合理的，而且我们现在做得单子大多数都是代理和回头客户介绍的所以一般现在有新的单子 我给客户的都是第一手的代理价格，因为我想坦诚对待大家 不想跟大家在价格方面浪费时间
对于老客户或者被老客户介绍过来的朋友，我们都会适当给一些优惠。
Exploring-Madhya-Pradesh-Culture-Heritage-and-Land-Records.pptx
Madhya Pradesh, the "Heart of India," boasts a rich tapestry of culture and heritage, from ancient dynasties to modern developments. Explore its land records, historical landmarks, and vibrant traditions. From agricultural expanses to urban growth, Madhya Pradesh offers a unique blend of the ancient and modern.
真实可查(nwu毕业证书)美国西北大学毕业证学位证书范本原版一模一样
原版定制【微信:bwp0011】《(nwu毕业证书)美国西北大学毕业证学位证书》【微信:bwp0011】成绩单 、雅思、外壳、留信学历认证永久存档查询，采用学校原版纸张、特殊工艺完全按照原版一比一制作（包括：隐形水印，阴影底纹，钢印LOGO烫金烫银，LOGO烫金烫银复合重叠，文字图案浮雕，激光镭射，紫外荧光，温感，复印防伪）行业标杆！精益求精，诚心合作，真诚制作！多年品质 ,按需精细制作，24小时接单,全套进口原装设备，十五年致力于帮助留学生解决难题，业务范围有加拿大、英国、澳洲、韩国、美国、新加坡，新西兰等学历材料，包您满意。
【业务选择办理准则】
一、工作未确定，回国需先给父母、亲戚朋友看下文凭的情况，办理一份就读学校的毕业证【微信bwp0011】文凭即可
二、回国进私企、外企、自己做生意的情况，这些单位是不查询毕业证真伪的，而且国内没有渠道去查询国外文凭的真假，也不需要提供真实教育部认证。鉴于此，办理一份毕业证【微信bwp0011】即可
三、进国企，银行，事业单位，考公务员等等，这些单位是必需要提供真实教育部认证的，办理教育部认证所需资料众多且烦琐，所有材料您都必须提供原件，我们凭借丰富的经验，快捷的绿色通道帮您快速整合材料，让您少走弯路。
留信网认证的作用:
1:该专业认证可证明留学生真实身份
2:同时对留学生所学专业登记给予评定
3:国家专业人才认证中心颁发入库证书
4:这个认证书并且可以归档倒地方
5:凡事获得留信网入网的信息将会逐步更新到个人身份内，将在公安局网内查询个人身份证信息后，同步读取人才网入库信息
6:个人职称评审加20分
7:个人信誉贷款加10分
8:在国家人才网主办的国家网络招聘大会中纳入资料，供国家高端企业选择人才
【关于价格问题（保证一手价格）】
我们所定的价格是非常合理的，而且我们现在做得单子大多数都是代理和回头客户介绍的所以一般现在有新的单子 我给客户的都是第一手的代理价格，因为我想坦诚对待大家 不想跟大家在价格方面浪费时间
对于老客户或者被老客户介绍过来的朋友，我们都会适当给一些优惠。
Singapore 2024 Sustainability Reporting and Accountancy Education Slides
Singapore 2024 Sustainability Reporting and Accountancy Education SlidesInternational Federation of Accountants
Singapore 2024 Sustainability Reporting and Accountancy Education SlidesCalculation of compliance cost: Veterinary and sanitary control of aquatic bi...
Calculation of compliance cost in the fishing industry of Russia after extended SCM model (Veterinary and sanitary control of aquatic biological resources (ABR) - Preparation of documents, passing expertise)
欧洲杯投注-欧洲杯投注买球-欧洲杯投注买球网|【网址🎉ac22.net🎉】
【网址🎉ac22.net🎉】欧洲杯投注 Sports 与其他博彩公司相比，其独特之处在于欧洲杯投注 Sports 基于低利润和高营业额的独一无二的体育博彩模式，该模式可以为玩家开出最高的赔率。欧洲杯投注的优势在于中文界面友好，接受人民币投注。他们的开户奖金和实时体育投注界面是大陆玩家的首选。
Understanding-Stocks-and-Real-Estate.pptx
Explore the world of investments with an in-depth comparison of the stock market and real estate. Understand their fundamentals, risks, returns, and diversification strategies to make informed financial decisions that align with your goals.
Monthly Market Risk Update: June 2024 [SlideShare]
Markets rallied in May, with all three major U.S. equity indices up for the month, said Sam Millette, director of fixed income, in his latest Market Risk Update.
For more market updates, subscribe to The Independent Market Observer at https://blog.commonwealth.com/independent-market-observer.
Governor Olli Rehn: Inflation down and recovery supported by interest rate cu...
Governor Olli Rehn
Bank of Finland
Press conference on the outlook for the Finnish economy
Helsinki, 11 June 2024
Navigating Your Financial Future: Comprehensive Planning with Mike Baumann
Learn how financial planner Mike Baumann helps individuals and families articulate their financial aspirations and develop tailored plans. This presentation delves into budgeting, investment strategies, retirement planning, tax optimization, and the importance of ongoing plan adjustments.
一比一原版宾夕法尼亚大学毕业证(UPenn毕业证书)学历如何办理
挂科购买【微信号:176555708】【挂科购买(UPenn毕业证书)】【微信号:176555708】《成绩单、外壳、offer、真实留信官方学历认证（永久存档/真实可查）》采用学校原版纸张、特殊工艺完全按照原版一比一制作（包括：隐形水印，阴影底纹，钢印LOGO烫金烫银，LOGO烫金烫银复合重叠，文字图案浮雕，激光镭射，紫外荧光，温感，复印防伪）行业标杆！精益求精，诚心合作，真诚制作！多年品质 ,按需精细制作，24小时接单,全套进口原装设备，十五年致力于帮助留学生解决难题，业务范围有加拿大、英国、澳洲、韩国、美国、新加坡，新西兰等学历材料，包您满意。
【我们承诺采用的是学校原版纸张（纸质、底色、纹路）我们拥有全套进口原装设备，特殊工艺都是采用不同机器制作，仿真度基本可以达到100%，所有工艺效果都可提前给客户展示，不满意可以根据客户要求进行调整，直到满意为止！】
【业务选择办理准则】
一、工作未确定，回国需先给父母、亲戚朋友看下文凭的情况，办理一份就读学校的毕业证【微信号:176555708】文凭即可
二、回国进私企、外企、自己做生意的情况，这些单位是不查询毕业证真伪的，而且国内没有渠道去查询国外文凭的真假，也不需要提供真实教育部认证。鉴于此，办理一份毕业证【微信号:176555708】即可
三、进国企，银行，事业单位，考公务员等等，这些单位是必需要提供真实教育部认证的，办理教育部认证所需资料众多且烦琐，所有材料您都必须提供原件，我们凭借丰富的经验，快捷的绿色通道帮您快速整合材料，让您少走弯路。
留信网认证的作用:
1:该专业认证可证明留学生真实身份
2:同时对留学生所学专业登记给予评定
3:国家专业人才认证中心颁发入库证书
4:这个认证书并且可以归档倒地方
5:凡事获得留信网入网的信息将会逐步更新到个人身份内，将在公安局网内查询个人身份证信息后，同步读取人才网入库信息
6:个人职称评审加20分
7:个人信誉贷款加10分
8:在国家人才网主办的国家网络招聘大会中纳入资料，供国家高端企业选择人才
留信网服务项目：
1、留学生专业人才库服务（留信分析）
2、国（境）学习人员提供就业推荐信服务
3、留学人员区块链存储服务
【关于价格问题（保证一手价格）】
我们所定的价格是非常合理的，而且我们现在做得单子大多数都是代理和回头客户介绍的所以一般现在有新的单子 我给客户的都是第一手的代理价格，因为我想坦诚对待大家 不想跟大家在价格方面浪费时间
对于老客户或者被老客户介绍过来的朋友，我们都会适当给一些优惠。
选择实体注册公司办理，更放心，更安全！我们的承诺：客户在留信官方认证查询网站查询到认证通过结果后付款，不成功不收费！
PM pre reads for the product manager framework
For kingfisher airlines, interpret this with product management frameworks and answer the below questions
Recently uploaded (20)
Exploring-Madhya-Pradesh-Culture-Heritage-and-Land-Records.pptx
Exploring-Madhya-Pradesh-Culture-Heritage-and-Land-Records.pptx
Singapore 2024 Sustainability Reporting and Accountancy Education Slides
Singapore 2024 Sustainability Reporting and Accountancy Education Slides
Calculation of compliance cost: Veterinary and sanitary control of aquatic bi...
Calculation of compliance cost: Veterinary and sanitary control of aquatic bi...
Monthly Market Risk Update: June 2024 [SlideShare]
Monthly Market Risk Update: June 2024 [SlideShare]
Governor Olli Rehn: Inflation down and recovery supported by interest rate cu...
Governor Olli Rehn: Inflation down and recovery supported by interest rate cu...
Navigating Your Financial Future: Comprehensive Planning with Mike Baumann
Navigating Your Financial Future: Comprehensive Planning with Mike Baumann
Pestle analysis on pharmaceutical industry
- 2. PESTEL ANALYSIS P – Political Environment E – Economical Environment S – Sociological Environment T – Technological Environment E – Ecological Environment L – Legal Environment Ranbaxy* Dr. Reddy's Cipla Lupin Nicholas Piramal Sun Pharmaceuticals GSK Cadila Healthcare Aurobindo Wockhardt* Generic Medicals
- 3. Political Environment It the country is having a good and business friendly environment, our pharma industry will develop more As our Prime Minister Narendra Modiji is having a schemes like Make in India, Start up India loan facilities at lower interest rates which will definitely makes a positive effects on a pharma industry.
- 4. Economical Environment If the economy is in a good way, it makes better opportunity to grow As 2015-16 budget is concerned our growth rate is accellerated to 7.6%, this is going to be a good sign for the pharma industry MODI’s govt. has allowed FDI in Pharma Industry(Start up India) It the economy is not good then it will be negative effect on Pharma Industry.
- 5. Sociological Environment Each and every business is totally depends on Sociological Environment Due to lack of knowledge among the people the pharma industry is lacking behind Knowledged society leads to the better business for the Pharmaceutical industry Social norms also influences its business Higher the population leads to higher the business
- 6. Technological Environment As a technology go on increasing, the pharma industry will get a lot of opportunities to do well business As it can get orders through online and it can have better cum low costly transactions. The Payments and receivables will be much easier to give and get on time. Technology helps pharma industry to produce or create a new drugs
- 7. Ecological Environment MANSOON is a best season for the pharmacetical industry as so many deceases comes in MANSOON and Winter Season If the nature is balanced it is going to be a bad sign for he Pharma Industry. Cool climate is better for the Pharma Industry to store its products in a safer manner.
- 8. Legal Environment Legal environment also effects a lot on Pharma industry As of now indian govt. has banned some of the drugs which is composed of Nimuslide.